Меню
Идёт набор NCT07203092

Effects of Transcranial Photobiomodulation in ADHD

Без фазы С лечением Attention Deficit Hyperactivity Disorder

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Active transcranial photobiomodulation, Sham transcranial photobiomodulation.
Кому может быть актуально
Состояния в реестре: Attention Deficit Hyperactivity Disorder. Базовые параметры: 18 лет — 44 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Effects of Transcranial Photobiomodulation on Cognition and Brain Metabolism in Adults With ADHD

Обзор

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

Подробное описание

This will be a double-blind, sham-controlled study to evaluate the neurobehavioral and PFC neurometabolic effects of repeated tPBM sessions in adults with ADHD. Adults with a history of medically-diagnosed ADHD will be recruited. Participants will be randomized to two arms: (1) active tPBM or (2) sham tPBM. All participants will complete three in-person sessions and one remote follow-up visit conducted online. Participant will receive three weekly sessions of tPBM targeting the PFC using a 1064 nm laser. Cognitive performance will be assessed using the continuous performance task and 2-back task at baseline and after the final tPBM session. The investigators predict that participants receiving active tPBM will show improvements in sustained attention, impulse control, and working memory. Functional near-infrared spectroscopy recordings, collected at baseline and post-treatment, will be used to evaluate changes in PFC hemodynamic response and network interactions (functional connectivity). The investigators predict that active tPBM will enhance the PFC hemodynamic response and strengthen network interactions across prefrontal subregions. Lastly, ADHD symptomatology will be assessed using the Adult ADHD Self-Report Scale at baseline, post-treatment, and at a four-week follow-up after tPBM. The investigators predict that participants receiving active tPBM will report progressive reductions in ADHD symptoms across time points.

Вмешательства

  • Устройство Active transcranial photobiomodulation
    Active transcranial photobiomodulation to the forehead targeting prefrontal cortex involves administration of 1064-nm light delivered via laser with a 4 centimeter beam diameter and 250 mW/cm2 power density for 8 minutes per treatment.
  • Устройство Sham transcranial photobiomodulation
    Identical procedure as active group, but without 1064-nm light emitted by the device.

Первичные конечные точки

  • Performance on the Continuous Performance Task [Срок оценки: 1. Pre-Treatment: Baseline (Visit 1). 2. Post-treatment: Two weeks later (Visit 3).]
  • Prefrontal oxygenation (functional near-infrared spectroscopy) [Срок оценки: 1. Pre-Treatment: Baseline (Visit 1). 2. Post-treatment: Two weeks later (Visit 3).]
  • Scores on the Adult ADHD Self-Report Scale (ASRS) questionnaire [Срок оценки: 1. Pre-Treatment: Baseline (Visit 1). 2. Post-treatment: Two weeks later (Visit 3). 3. Follow-up: Four weeks later (Online).]

Критерии участия

Критерии включения

  • English-speaking
  • Adults of any sex
  • Age range: 18-44 years
  • Any ethnic/racial background
  • Medical history of ADHD
  • Participants may either be on a stable ADHD medication regimen (with no changes within two weeks prior to the study) or not taking medication.

Критерии исключения

  • Currently pregnancy
  • Any sham or active photobiomodulation treatment within the past five weeks.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Двойное слепое
Основная цель
Лечение

Центры проведения

США · 1 центр
  • The University of Texas at Austin — Austin

Идентификаторы

NCT: NCT07203092 · STUDY00007909

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗